Anti-FZD重组抗体|科研级 Vantictumab ( 万替妥单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-FZD重组抗体|科研级 Vantictumab ( 万替妥单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-FZD重组抗体|科研级 Vantictumab ( 万替妥单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1315

Alias

科研级 Vantictumab ( 万替妥单抗 ), Anti-FZD Recombinant Antibody, Research Grade Vantictumab

Molecular Name

Vantictumab

Size

1mg, 5mg

CAS Number

1345009-45-1

Isotype

IgG2 Lambda

Clonality

Monoclonal

Concentration

1mg/ml

Applications

Inhibition, Flow Cyt

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

FZD[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Vantictumab /v?n?t?kt?m?b/ is a human IgG2 monoclonal antibody designed for the treatment of cancer. This drug was developed by OncoMed Pharmaceuticals Inc. in partnership with Bayer. OncoMed was awarded a patent in 2016, which is set to expire in 2029.[3] In April 2017, Bayer terminated its option to license vantictumab.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ